Gastric cancer in Africa: Current management and outcomes

Table 2 Treatment and survival outcome

Country	Year of publication and study design	Author	Sample size	Overall survival	Treatment	Post-operative complication	Post-operative mortality	Incidence and Mortality rate per Globocan
Tanzania	2012, retrospective review	Mabula et al[15]	232	5 yr survival: 32.8%	Surgery: 223/232 (96.1%)	37.1%	18.1%	2/100000
					Chemotherapy: 56 (24%)			2/100000
					Radiotherapy: 12 (5.1%)
Mali (Abstract, French article)	2012	Dembeleet al[17]	425	1 yr survival: 15.5%	200 (65%): surgery	-	-	20.3/100000
					105 (34.3%) : no surgery			19.7/100000
					4 (1.3%): chemotherapy
Nigeria	2011, retrospective review	Ahmed et al[16]	179	13.6 mo	Surgery: 155 (86.6%)	43 (27.7%)	25 (16.1%)	2.2/100000
				1 yr post gastrectomy: 70.1%				2.1/100000
				5 yr post gastrectomy: 21.8%
Zimbabwe	2011	Chokunonga et al[18]	-	5 yr survival: 20%	-	-	-	5.3/100000
								5/100000
Nigeria	2010, retrospective	Osime et al[19]	-	mortality rate 39.1; 66% died within one year of diagnosis	30.4% presented within in year			2.2/100000
								2.1/100000
Tunisia (Abstract, French article)	2006, retrospective	Arfaouiet al[24]	140	26.5 mo, 13 mo and 5 mo after curative resection, palliative resection and without resection	Curative and palliative resection
Tunisia (Abstract, French article)	2004	Ayite et al[23]	63	3 mo: 21%				4.2/10000000
				1 yr survival: 7%				3.9/100000
Senegal (Abstract, French article)	2003	Fall et al[20]	60	Total overall survival : 20%	-	-	-	6.1/100000 5.9/100000
Uganda	2001, prospective, descriptive	Ibingira[21]	35	1 yr survival after partial gastrectomy: 39.1% -	94.5% presented with advanced cancer, and no curative surgery possible			9/100000
								8.7/100000
Ethiopia	2000, prospective	Johnson et al[22]	96		90% presented in advanced stage;	-	18.6%	3.5/100000
					40% had resectable lesions			3.4/100000